Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Circulerend tumor-DNA als biomarker bij pancreascarcinoom
sep 2019 | Maag-darm-leveroncologie